NASDAQ : ECOR
electroCore, Inc. — Key statistics
Healthcare · Medical Devices · United States
Last price 7.52 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 67.80M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 67.80M |
| Enterprise Value | 67.32M |
Dates
| Measure | Value |
|---|
| Earnings Date | Nov 4, 2026 |
| Ex-Dividend Date | n/a |
Shares
| Measure | Value |
|---|
| Current Share Class | 9.02M |
| Shares Outstanding | 9.02M |
| Shares Change (YoY) | +8.56% |
| Shares Change (QoQ) | +5.04% |
| Owned by Insiders (%) | 28.01% |
| Owned by Institutions (%) | 13.64% |
| Float | 5.98M |
Ratios
| Measure | Value |
|---|
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 1.83 |
| Forward PS | 1.44 |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Evratios
| Measure | Value |
|---|
| EV / Earnings | n/a |
| EV / Sales | 1.82 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.21 |
| Quick Ratio | 0.94 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.41 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -55.00% |
| Return on Invested Capital (ROIC) | -143.50% |
| Return on Capital Employed (ROCE) | -258.13% |
| Weighted Average Cost of Capital (WACC) | 10.05% |
| Revenue Per Employee | $445,373 |
| Profits Per Employee | -$177,952 |
| Employee Count | 83 |
| Asset Turnover | 2.34 |
| Inventory Turnover | 2.49 |
Taxes
| Measure | Value |
|---|
| Income Tax | -270,000 |
| Effective Tax Rate | n/a |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 1.05 |
| 52-Week Price Change | +49.21% |
| 50-Day Moving Average | 9.50 |
| 200-Day Moving Average | 7.74 |
| Relative Strength Index (RSI) | 37.54 |
| Average Volume (20 Days) | 71,748 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 347,679 |
| Short Previous Month | 314,260 |
| Short % of Shares Out | 3.86% |
| Short % of Float | 5.81% |
| Short Ratio (days to cover) | 3.75 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 36.97M |
| Gross Profit | 32.18M |
| Operating Income | -13.91M |
| Pretax Income | -15.04M |
| Net Income | -14.77M |
| EBITDA | -13.66M |
| EBIT | -13.91M |
| Loss Per Share | -$1.66 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 10.04M |
| Total Debt | 9.56M |
| Net Cash | 481,000 |
| Net Cash Per Share | $0.05 |
| Equity (Book Value) | -2.79M |
| Book Value Per Share | -0.31 |
| Working Capital | 2.45M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | -9.74M |
| Capital Expenditures | -10,000 |
| Depreciation & Amortization | 252,000 |
| Net Borrowing | 7.50M |
| Free Cash Flow | -9.75M |
| FCF Per Share | -$1.08 |
Margins
| Measure | Value |
|---|
| Gross Margin | 87.06% |
| Operating Margin | -37.64% |
| Pretax Margin | -40.69% |
| Profit Margin | -39.96% |
| EBITDA Margin | -36.96% |
| EBIT Margin | -37.64% |
| FCF Margin | n/a |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -8.56% |
| Shareholder Yield | -8.56% |
| Earnings Yield | -22.01% |
| FCF Yield | -14.37% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $19.17 |
| Price Target Difference | 154.92% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 29.21% |
| EPS Growth Forecast (3Y) | n/a |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | Feb 15, 2023 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | -15.23 |
| Piotroski F-Score | 4 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |